The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure
CA 2185998 C · Owner: Yang, Renhui · Inventors: Paoni, Nicholas F.; Jin, Hongkui; Yang, Renhui
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of enhancing, myocardial contractility and cardiac performance in a mammal, with congestive heart failure are disclosed. In a first method a, mammal with congestive heart failure is treated by administering, to the mammal an effective amount of a combination of growth, hormone (GH) and insulin-like growth factor (IGF-I). A second, method comprises administering to the mammal an effective amount of, a combination of GH and IGF-I in the presence of an ACE inhibitor. This method results in enhancement of myocardial contractility and, cardiac performance above the level achieved with ACE inhibition, alone. Preferably the mammal is a human.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 30, 1995 and granted February 22, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 30, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 30, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.